STOCK TITAN

Yarrow Bioscience: RTW reports 9.99% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Yarrow Bioscience, Inc. (YARW) reports an amended ownership position by RTW Fund Group GP, LLC, manager of RTW Entity, and Roderick Wong, M.D., the manager’s managing member. As of September 30, 2026, each reported beneficial ownership of 1,145,149 shares, or 9.99%, with shared voting and dispositive power; RTW Entity directly holds the shares. The reported amount assumes exercise of warrants only to the maximum extent permitted. The warrants cannot be exercised if doing so would cause beneficial ownership to exceed 9.99% of outstanding shares. RTW Entity has the right to receive dividends or sale proceeds from the shares. The statement says the reported ownership is not an admission of beneficial ownership for purposes of Section 13.

Beneficially owned shares 1,145,149 shares Reported by each reporting person as of September 30, 2026; amount assumes maximum permissible warrant exercise.
Percent of class 9.99% Reported for each reporting person as of September 30, 2026.
beneficial ownership regulatory
"beneficial ownership of the Shares reported herein"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Shared Voting Power regulatory
"Shared Voting Power over 1,145,149 Shares"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Power regulatory
"Shared Dispositive Power over 1,145,149 Shares"
Warrants financial
"exercise of the Warrants to the maximum extent permissible"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many YARW shares did RTW Fund Group and Roderick Wong report owning?

RTW Fund Group GP, LLC and Roderick Wong, M.D. each reported beneficial ownership of 1,145,149 YARW shares, or 9.99%, as of September 30, 2026. The amount assumes warrants were exercised to the maximum extent permitted under their terms.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





92941V407

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



RTW Fund Group GP, LLC
Signature:/s/ Roderick Wong, M.D.
Name/Title:Roderick Wong, M.D., Managing Member
Date:11/16/2026
Roderick Wong
Signature:/s/ Roderick Wong, M.D.
Name/Title:Roderick Wong, M.D.
Date:11/16/2026
Exhibit Information

Exhibit 99.1 Joint Filing Agreement (incorporated by reference to Exhibit 99.1 to the Reporting Persons' Schedule 13G filed with the SEC on July 30, 2026).

Keep reading